Shandong Keyuan Pharmaceutical Co. Ltd. A Tangible Net Worth Ratio
Shandong Keyuan Pharmaceutical Co. Ltd. A tangible net worth ratio. Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Tangible Net Worth Ratio of 91.5% as of June 2025. This metric is calculated by deducting intangible assets (CN¥117.17 Million) from net assets (CN¥1.38 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 301281 net asset quality score to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Tangible net worth ratio of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024. This chart shows how Shandong Keyuan Pharmaceutical Co. Ltd. A's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 91.5%, reflecting net assets of CN¥1.38 Billion with intangible assets of CN¥117.17 Million CNY. See 301281 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Shandong Keyuan Pharmaceutical Co. Ltd. A Tangible Net Worth Ratio by Year (2021–2024)
Shandong Keyuan Pharmaceutical Co. Ltd. A tangible net worth ratio by year from 2021 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 301281 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 92.0% | CN¥1.36 Billion | CN¥108.98 Million | CN¥1.55 Billion | ▼ -4.6 pp |
| 2023 | 96.5% | CN¥1.33 Billion | CN¥46.02 Million | CN¥1.47 Billion | ▲ +6.0 pp |
| 2022 | 90.6% | CN¥519.73 Million | CN¥49.08 Million | CN¥651.79 Million | ▲ +2.6 pp |
| 2021 | 88.0% | CN¥430.98 Million | CN¥51.76 Million | CN¥559.51 Million | — |